Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01684722 · ClinicalTrials.gov registry record · NA
Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 1,312
- Enrollment target
NCT01684722 is a NA study that has completed, run by University of Washington. The registered enrollment target is 1,312 participants.
The verdict
NCT01684722, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,312 participants
- Enrollment target
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 20,000 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL with a history of diabetes and will examine whether vitamin D or fish oil prevents the development and progression of diabetic kidney disease.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- DIETARY_SUPPLEMENT Fish oil placebo
- DRUG Omega-3 fatty acids (fish oil)
- DIETARY_SUPPLEMENT Vitamin D placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,312 participants |
| Start Date | 2010-07 |
| Est. Completion | 2019-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01684722
The ClinicalTrials.gov registry entry for NCT01684722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vitamin D is the first listed.
NCT01684722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01684722 about?
NCT01684722 is a clinical study titled "Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease". The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 20,000 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and strok...
What is the current status of trial NCT01684722?
This trial is currently completed. It is a NA study. The enrollment target is 1,312 participants. The study started on 2010-07. Estimated completion is 2019-11-08.
What interventions are being tested in trial NCT01684722?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), Omega-3 fatty acids (fish oil) (DRUG), Vitamin D placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01684722?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.